Market Overview:
The global thrombectomy devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of thrombotic disorders, technological advancements in thrombectomy devices, and rising demand for minimally invasive procedures. The global thrombectomy devices market is segmented on the basis of type into automated thrombectomy devices and manual thrombectomy devices. The automated segment is expected to grow at a higher CAGR than the manual segment during the forecast period from 2018 to 2030. This can be attributed to the advantages offered by automated over manual thrombectomy devices such as accuracy, precision, and reduced procedural time.
Product Definition:
A thrombectomy device is a medical tool used to remove blood clots from the body. These devices can be inserted into the body through a vein or artery, and work to break up and remove the clot. They are often used in cases of stroke, where a blood clot has blocked the flow of blood to the brain.
Automated Thrombectomy Devices:
Automated thrombectomy devices are used for the removal of blood clots from various body parts including lungs, kidney, and heart. It is a minimally invasive procedure that involves the use of laser or ultrasound technology to break up the clot and remove it from the affected part. The major advantage associated with this procedure is that there’s no need for open-heart surgery which was earlier performed in case of removing clots manually.
Manual Thrombectomy Devices:
Manual thrombectomy devices are used for the removal of blood clots from the blood vessels. It is a procedure that is performed by healthcare professionals and it helps them to remove the clot manually. The manual thrombectomy devices market includes products such as aspiration, ultrasonic, and laser devices among others.
Application Insights:
Peripheral and coronary thrombectomy are the major application segments of the global market. Peripheral procedures include catheter based and surgical techniques for accessing arteries. Surgical techniques comprise embolization, stent placement, atherectomy, and others. The use of these devices in peripheral procedures is expected to drive growth over the forecast period due to increasing incidence of stroke caused by blood clotting in small vessels within the brain.
The coronary segment is anticipated to witness significant growth during the forecast period owing to rising prevalence of heart diseases such as CHD (coronary artery disease), CVDs (cardiovascular diseases), and others (aortic aneurysm). According to a study published by NCBI in 2018, it was estimated that around 1 billion people across all age groups were affected by some form of cardiovascular disease globally which accounted for around 30%of all deaths worldwide.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the incidence of heart diseases, increasing prevalence of cancer, and presence of well-established healthcare facilities. Moreover, availability of reimbursement policies for thrombectomy devices is also expected to drive growth during the forecast period. Europe accounted for over 25% share in terms of revenue due to growing demand for minimally invasive surgeries coupled with rising awareness about available treatment options.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to rapidly improving healthcare infrastructure and economic development leading to an increase in disposable income which will ultimately result an increased number of patients opting for various surgical procedures including coronary bypass and other types off cardiovascular surgeries.
Growth Factors:
- Increasing incidence of stroke: The number of people affected by stroke is increasing at an alarming rate across the globe. This is mainly due to the changing lifestyle and growing population. According to the World Health Organization (WHO), approximately 15 million people suffer from a stroke every year, out of which 5 million die and another 5 million are left permanently disabled. The number of thrombectomy devices required for treating these patients is thus expected to grow significantly in the coming years.
- Technological advancements: Thrombectomy devices are constantly evolving with new technological advancements being made in order to make them more effective and safe for use. This is likely to result in increased demand for these devices in the near future as healthcare providers look for better ways to treat patients suffering from strokes caused by blood clots.
- Growing awareness about thrombectomy procedures: There has been a significant increase in awareness about thrombectomy procedures among both doctors and patients over recent years, owing largely to successful marketing campaigns by device manufacturers and clinical studies that have highlighted the benefits of such treatments over traditional methods like medication or surgery alone.. As a result, there has been an increase in demand for thrombectomy devices worldwide, especially among those regions where such treatments are not yet commonly used..
Scope Of The Report
Report Attributes
Report Details
Report Title
Thrombectomy Devices Market Research Report
By Type
Automated Thrombectomy Devices, Manual Thrombectomy Devices
By Application
Peripheral, Coronary, Neural
By Companies
Boston Scientific, Medtronic, Teleflex, Penumbra, The Spectranetics, AngioDynamics, Terumo, Johnson and Johnson, Stryker Corporation, Vascular Solutions, Boston Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Thrombectomy Devices Market Report Segments:
The global Thrombectomy Devices market is segmented on the basis of:
Types
Automated Thrombectomy Devices, Manual Thrombectomy Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Peripheral, Coronary, Neural
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Medtronic
- Teleflex
- Penumbra
- The Spectranetics
- AngioDynamics
- Terumo
- Johnson and Johnson
- Stryker Corporation
- Vascular Solutions
- Boston Scientific
Highlights of The Thrombectomy Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Automated Thrombectomy Devices
- Manual Thrombectomy Devices
- By Application:
- Peripheral
- Coronary
- Neural
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thrombectomy Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Thrombectomy devices are medical devices used to remove blood clots from the body.
Some of the major companies in the thrombectomy devices market are Boston Scientific, Medtronic, Teleflex, Penumbra, The Spectranetics, AngioDynamics, Terumo, Johnson and Johnson, Stryker Corporation, Vascular Solutions, Boston Scientific.
The thrombectomy devices market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thrombectomy Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thrombectomy Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thrombectomy Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thrombectomy Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thrombectomy Devices Market Size & Forecast, 2018-2028
4.5.1 Thrombectomy Devices Market Size and Y-o-Y Growth
4.5.2 Thrombectomy Devices Market Absolute $ Opportunity
Chapter 5 Global Thrombectomy Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Thrombectomy Devices Market Size Forecast by Type
5.2.1 Automated Thrombectomy Devices
5.2.2 Manual Thrombectomy Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Thrombectomy Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Thrombectomy Devices Market Size Forecast by Applications
6.2.1 Peripheral
6.2.2 Coronary
6.2.3 Neural
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thrombectomy Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thrombectomy Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Thrombectomy Devices Analysis and Forecast
9.1 Introduction
9.2 North America Thrombectomy Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Thrombectomy Devices Market Size Forecast by Type
9.6.1 Automated Thrombectomy Devices
9.6.2 Manual Thrombectomy Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Thrombectomy Devices Market Size Forecast by Applications
9.10.1 Peripheral
9.10.2 Coronary
9.10.3 Neural
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Thrombectomy Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Thrombectomy Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Thrombectomy Devices Market Size Forecast by Type
10.6.1 Automated Thrombectomy Devices
10.6.2 Manual Thrombectomy Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Thrombectomy Devices Market Size Forecast by Applications
10.10.1 Peripheral
10.10.2 Coronary
10.10.3 Neural
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Thrombectomy Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Thrombectomy Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Thrombectomy Devices Market Size Forecast by Type
11.6.1 Automated Thrombectomy Devices
11.6.2 Manual Thrombectomy Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Thrombectomy Devices Market Size Forecast by Applications
11.10.1 Peripheral
11.10.2 Coronary
11.10.3 Neural
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Thrombectomy Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Thrombectomy Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Thrombectomy Devices Market Size Forecast by Type
12.6.1 Automated Thrombectomy Devices
12.6.2 Manual Thrombectomy Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Thrombectomy Devices Market Size Forecast by Applications
12.10.1 Peripheral
12.10.2 Coronary
12.10.3 Neural
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Thrombectomy Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Thrombectomy Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Thrombectomy Devices Market Size Forecast by Type
13.6.1 Automated Thrombectomy Devices
13.6.2 Manual Thrombectomy Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Thrombectomy Devices Market Size Forecast by Applications
13.10.1 Peripheral
13.10.2 Coronary
13.10.3 Neural
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thrombectomy Devices Market: Competitive Dashboard
14.2 Global Thrombectomy Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 Medtronic
14.3.3 Teleflex
14.3.4 Penumbra
14.3.5 The Spectranetics
14.3.6 AngioDynamics
14.3.7 Terumo
14.3.8 Johnson and Johnson
14.3.9 Stryker Corporation
14.3.10 Vascular Solutions
14.3.11 Boston Scientific
